Evidence map›Paper›PMID 24608696›Full record

ArticlePloS one2014

Gender-specific potential inhibitory role of Ca2+/calmodulin dependent protein kinase phosphatase (CaMKP) in pressure-overloaded mouse heart.

Miresta Prévilon, Mylène Pezet, Laurent Vinet, Jean-Jacques Mercadier, Patricia Rouet-Benzineb

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. New Insights in RBM20 Cardiomyopathy.Current heart failure reports · 2020
    Review
  4. Sex-Specific Features of Calcific Aortic Valve Disease.International journal of molecular sciences · 2020
    Review
  5. Gender Differences in Cardiac Hypertrophy.Journal of cardiovascular translational research · 2020
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Miresta PrévilonInserm, UMRS-698, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Mylène PezetCEFI-Institut Claude Bernard-IFR02, Paris, France; Inserm, U823, Plateforme de Microscopie Photonique - Cytométrie en Flux, Institut Albert Bonniot Site Santé BP170-38042, Grenoble, France.
Laurent VinetInserm, UMRS-698, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Department of Cell Physiology and Metabolism, University of Geneva, Medical School, Genève, Switzerland.
Jean-Jacques MercadierUniversité Paris Diderot, Sorbonne Paris Cité, Paris, France; Inserm, UMRS-769, Université Paris-Sud, IFR141, LabEx LERMIT, Châtenay-Malabry, France; AP-HP, Hôpital Bichat, Paris, France.
Patricia Rouet-BenzinebInserm, UMRS-698, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRDélégation Paris 7 · FRInserm · FRSorbonne Paris Cité · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCa2+/calmodulin-dependent protein kinase phosphatase (CaMKP) has been proposed as a potent regulator of multifunctional Ca2+/calmodulin-dependent protein kinases (i.e., CaMKII). The CaMKII-dependent activation of myocyte enhancer factor 2 (MEF2) disrupts interactions between MEF2-histone deacetylases (HDACs), thereby de-repressing downstream gene transcription. Whether CaMKP modulates the CaMKII- MEF2 pathway in the heart is unknown. Here, we investigated the molecular and functional consequences of left ventricular (LV) pressure overload in the mouse of both genders, and in particular we evaluated the expression levels and localization of CaMKP and its association with CaMKII-MEF2 signaling. METHODOLOGY AND PRINCIPAL

findingsFive week-old B6D1/F1 mice of both genders underwent a sham-operation or thoracic aortic constriction (TAC). Thirty days later, TAC was associated with pathological LV hypertrophy characterized by systolic and diastolic dysfunction. Gene expression was assessed by real-time PCR. Fetal gene program re-expression comprised increased RNA levels of brain natriuretic peptide and alpha-skeletal actin. Mouse hearts of both genders expressed both CaMKP transcript and protein. Activation of signalling pathways was studied by Western blot in LV lysates or subcellular fractions (nuclear and cytoplasmic). TAC was associated with increased CaMKP expression in male LVs whereas it tended to be decreased in females. The DNA binding activity of MEF2 was determined by spectrophotometry. CaMKP compartmentalization differed according to gender. In male TAC mice, nuclear CaMKP was associated with inactive CaMKII resulting in less MEF2 activation. In female TAC mice, active CaMKII (phospho-CaMKII) detected in the nuclear fraction, was associated with a strong MEF2 transcription factor-binding activity. CONCLUSIONS/SIGNIFICANCE: Gender-specific CaMKP compartmentalization is associated with CaMKII-mediated MEF2 activation in pressure-overloaded hearts. Therefore, CaMKP could be considered as an important novel cellular target for the development of new therapeutic strategies for heart diseases.

Indexed as

AnimalsCardiomegalyFemaleHypertensionMaleMEF2 Transcription FactorsMiceMyocardiumPhosphoprotein PhosphatasesSex CharacteristicsVentricular Remodelingcalmodulin dependent protein kinase II phosphataseMEF2 Transcription FactorsPhosphoprotein Phosphatases

Identifiers

PMID24608696
PMCPMC3946626
OpenAlexW2000165149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.